Comparison of two difference antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomised controlled study.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Imidafenacin (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 02 Sep 2011 Results presented at the 41st Annual Meeting of the International Continence Society.
- 27 Jul 2011 New trial record